Found 42 Enz. Inhib. hit(s) with all data for entry = 50034431 
Affinity DataIC50: 0.0680nMAssay Description:Displacement of [I125]deltorphin from delta-opioid receptor overexpressed in human HEK293 cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 0.0710nMAssay Description:Displacement of [I125]deltorphin from delta-opioid receptor overexpressed in human HEK293 cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 0.0940nMAssay Description:Displacement of [I125]deltorphin from delta-opioid receptor overexpressed in human HEK293 cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 0.260nMAssay Description:Displacement of [I125]deltorphin from delta-opioid receptor overexpressed in human HEK293 cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 0.270nMAssay Description:Displacement of [I125]deltorphin from delta-opioid receptor overexpressed in human HEK293 cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 0.290nMAssay Description:Displacement of [I125]deltorphin from delta-opioid receptor overexpressed in human HEK293 cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 0.350nMAssay Description:Displacement of [I125]deltorphin from delta-opioid receptor overexpressed in human HEK293 cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 0.680nMAssay Description:Displacement of [I125]deltorphin from delta-opioid receptor overexpressed in human HEK293 cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 0.700nMAssay Description:Displacement of [I125]deltorphin from delta-opioid receptor overexpressed in human HEK293 cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 0.780nMAssay Description:Displacement of [I125]deltorphin from delta-opioid receptor overexpressed in human HEK293 cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 0.900nMAssay Description:Displacement of [I125]deltorphin from delta-opioid receptor overexpressed in human HEK293 cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 1.10nMAssay Description:Displacement of [I125]deltorphin from delta-opioid receptor overexpressed in human HEK293 cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 1.30nMAssay Description:Displacement of [I125]deltorphin from delta-opioid receptor overexpressed in human HEK293 cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 1.40nMAssay Description:Displacement of [I125]deltorphin from delta-opioid receptor overexpressed in human HEK293 cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 2nMAssay Description:Displacement of [I125]deltorphin from delta-opioid receptor overexpressed in human HEK293 cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 4.10nMAssay Description:Displacement of [I125]deltorphin from delta-opioid receptor overexpressed in human HEK293 cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 4.70nMAssay Description:Displacement of [I125]deltorphin from delta-opioid receptor overexpressed in human HEK293 cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 5.20nMAssay Description:Displacement of [I125]deltorphin from delta-opioid receptor overexpressed in human HEK293 cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 6.60nMAssay Description:Displacement of [I125]deltorphin from delta-opioid receptor overexpressed in human HEK293 cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 23nMAssay Description:Displacement of [I125]deltorphin from delta-opioid receptor overexpressed in human HEK293 cellsMore data for this Ligand-Target Pair
Affinity DataIC50: >100nMAssay Description:Displacement of [I125]deltorphin from delta-opioid receptor overexpressed in human HEK293 cellsMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Astrazeneca Pharmaceuticals
Curated by ChEMBL
Astrazeneca Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 3.60E+3nMAssay Description:Inhibition of human ErgMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Astrazeneca Pharmaceuticals
Curated by ChEMBL
Astrazeneca Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 5.40E+3nMAssay Description:Inhibition of human ErgMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Astrazeneca Pharmaceuticals
Curated by ChEMBL
Astrazeneca Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 7.30E+3nMAssay Description:Inhibition of human ErgMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Astrazeneca Pharmaceuticals
Curated by ChEMBL
Astrazeneca Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 8.70E+3nMAssay Description:Inhibition of human ErgMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Astrazeneca Pharmaceuticals
Curated by ChEMBL
Astrazeneca Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 9.90E+3nMAssay Description:Inhibition of human ErgMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Astrazeneca Pharmaceuticals
Curated by ChEMBL
Astrazeneca Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 1.10E+4nMAssay Description:Inhibition of human ErgMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Astrazeneca Pharmaceuticals
Curated by ChEMBL
Astrazeneca Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 1.10E+4nMAssay Description:Inhibition of human ErgMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Astrazeneca Pharmaceuticals
Curated by ChEMBL
Astrazeneca Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 1.10E+4nMAssay Description:Inhibition of human ErgMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Astrazeneca Pharmaceuticals
Curated by ChEMBL
Astrazeneca Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 1.30E+4nMAssay Description:Inhibition of human ErgMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Astrazeneca Pharmaceuticals
Curated by ChEMBL
Astrazeneca Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 1.30E+4nMAssay Description:Inhibition of human ErgMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Astrazeneca Pharmaceuticals
Curated by ChEMBL
Astrazeneca Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 1.40E+4nMAssay Description:Inhibition of human ErgMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Astrazeneca Pharmaceuticals
Curated by ChEMBL
Astrazeneca Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 1.50E+4nMAssay Description:Inhibition of human ErgMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Astrazeneca Pharmaceuticals
Curated by ChEMBL
Astrazeneca Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 1.50E+4nMAssay Description:Inhibition of human ErgMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Astrazeneca Pharmaceuticals
Curated by ChEMBL
Astrazeneca Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 1.70E+4nMAssay Description:Inhibition of human ErgMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Astrazeneca Pharmaceuticals
Curated by ChEMBL
Astrazeneca Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 1.80E+4nMAssay Description:Inhibition of human ErgMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Astrazeneca Pharmaceuticals
Curated by ChEMBL
Astrazeneca Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of human ErgMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Astrazeneca Pharmaceuticals
Curated by ChEMBL
Astrazeneca Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 2.80E+4nMAssay Description:Inhibition of human ErgMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Astrazeneca Pharmaceuticals
Curated by ChEMBL
Astrazeneca Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: >3.00E+4nMAssay Description:Inhibition of human ErgMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Astrazeneca Pharmaceuticals
Curated by ChEMBL
Astrazeneca Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: >3.30E+4nMAssay Description:Inhibition of human ErgMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Astrazeneca Pharmaceuticals
Curated by ChEMBL
Astrazeneca Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: >3.30E+4nMAssay Description:Inhibition of human ErgMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Astrazeneca Pharmaceuticals
Curated by ChEMBL
Astrazeneca Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: >3.30E+4nMAssay Description:Inhibition of human ErgMore data for this Ligand-Target Pair
